RHUMBLINE ADVISERS - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 106 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.3%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q1 2021$199,000
+54.3%
100,894
-2.0%
0.00%
Q4 2020$129,000
-19.4%
102,904
+15.7%
0.00%
Q3 2020$160,000
-81.3%
88,914
-12.7%
0.00%
-100.0%
Q2 2020$855,000
+98.8%
101,864
+24.3%
0.00%0.0%
Q1 2020$430,000
-2.5%
81,971
+1.4%
0.00%0.0%
Q4 2019$441,000
+15.4%
80,851
+3.1%
0.00%0.0%
Q3 2019$382,000
-30.0%
78,442
-0.5%
0.00%0.0%
Q2 2019$546,000
+16.4%
78,837
+16.7%
0.00%0.0%
Q1 2019$469,000
+24.1%
67,529
+4.4%
0.00%0.0%
Q4 2018$378,000
+18.5%
64,689
+52.9%
0.00%0.0%
Q3 2018$319,000
+38.7%
42,310
-7.0%
0.00%
Q2 2018$230,000
-11.5%
45,510
+6.8%
0.00%
-100.0%
Q1 2018$260,000
-1.1%
42,600
+15.0%
0.00%0.0%
Q4 2017$263,000
-19.3%
37,050
-18.8%
0.00%0.0%
Q3 2017$326,000
+15.2%
45,645
+1.5%
0.00%0.0%
Q2 2017$283,00044,9750.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q2 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$42,335,00024.44%
MANGROVE PARTNERS IM, LLC 552,200$4,633,0001.13%
ETF MANAGERS GROUP, LLC 3,707,912$31,109,0001.10%
Ikarian Capital, LLC 1,350,000$11,327,0000.90%
GENERAL AMERICAN INVESTORS CO INC 712,400$5,977,0000.76%
AdvisorShares Investments LLC 189,814$1,593,0000.68%
Ikarian Capital, LLC 1,000,000$8,390,0000.67%
Granite Point Capital Management, L.P. 1,123,600$9,427,0000.48%
Carmignac Gestion 3,773,440$31,659,0000.44%
Omnia Family Wealth, LLC 32,356$271,467,0000.27%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders